Skip to main content
NCBI home page
Critical Care logoLink to Critical Care
. 2011 Feb 25;15(1):R72. doi: 10.1186/cc10061

A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis

Constantine J Karvellas 1, Maha R Farhat 2, Imran Sajjad 3, Simon S Mogensen 4, Alexander A Leung 5, Ron Wald 6, Sean M Bagshaw 1,✉
PMCID: PMC3222005  PMID: 21352532

Abstract

Introduction

Our aim was to investigate the impact of early versus late initiation of renal replacement therapy (RRT) on clinical outcomes in critically ill patients with acute kidney injury (AKI).

Methods

Systematic review and meta-analysis were used in this study. PUBMED, EMBASE, SCOPUS, Web of Science and Cochrane Central Registry of Controlled Clinical Trials, and other sources were searched in July 2010. Eligible studies selected were cohort and randomised trials that assessed timing of initiation of RRT in critically ill adults with AKI.

Results

We identified 15 unique studies (2 randomised, 4 prospective cohort, 9 retrospective cohort) out of 1,494 citations. The overall methodological quality was low. Early, compared with late therapy, was associated with a significant improvement in 28-day mortality (odds ratio (OR) 0.45; 95% confidence interval (CI), 0.28 to 0.72). There was significant heterogeneity among the 15 pooled studies (I2 = 78%). In subgroup analyses, stratifying by patient population (surgical, n = 8 vs. mixed, n = 7) or study design (prospective, n = 10 vs. retrospective, n = 5), there was no impact on the overall summary estimate for mortality. Meta-regression controlling for illness severity (Acute Physiology And Chronic Health Evaluation II (APACHE II)), baseline creatinine and urea did not impact the overall summary estimate for mortality. Of studies reporting secondary outcomes, five studies (out of seven) reported greater renal recovery, seven (out of eight) studies showed decreased duration of RRT and five (out of six) studies showed decreased ICU length of stay in the early, compared with late, RRT group. Early RRT did not; however, significantly affect the odds of dialysis dependence beyond hospitalization (OR 0.62 0.34 to 1.13, I2 = 69.6%).

Conclusions

Earlier institution of RRT in critically ill patients with AKI may have a beneficial impact on survival. However, this conclusion is based on heterogeneous studies of variable quality and only two randomised trials. In the absence of new evidence from suitably-designed randomised trials, a definitive treatment recommendation cannot be made.

Introduction

Acute kidney injury (AKI) is a serious complication of critical illness that is associated with substantial morbidity and mortality [1-7]. Extracorporeal renal replacement therapy (RRT) has long been used as supportive treatment of AKI, and has traditionally focused on averting the life-threatening derangements associated with kidney failure (that is, metabolic acidosis, hyperkalemia, uremia, and/or fluid overload) while allowing time for organ recovery. Observations from a large multinational, multicenter survey found the prevalence of severe AKI supported with RRT in critically ill patients was approximately 6% [7].

A critical decision in the support of critically ill patients with AKI is when to initiate RRT. Data have emerged to suggest that earlier RRT initiation may attenuate kidney-specific and non-kidney organ injury from acidemia, uremia, fluid overload, and systemic inflammation [8,9]. This in turn, may potentially translate into improved survival and earlier recovery of kidney function [9]. Unfortunately, in the absence of refractory acidemia, toxic hyperkalemia and intravascular fluid overload contributing to respiratory failure, there is limited evidence to guide clinicians on when to initiate RRT in critically ill patients with AKI. The question of timing of initiation of RRT (that is, "early" versus "late") has seldom been the focus of high-quality or rigorous evaluation [10-23]. As a consequence, initiatives aimed at identifying the "optimal timing of initiation of RRT" in AKI have been given the highest priority for investigation by the Acute Kidney Injury Network (AKIN) [24,25].

Accordingly, we conducted a systematic review and meta-analysis to determine whether "early" versus "late" initiation of RRT in critically ill patients with AKI is associated with a survival benefit or more favourable renal recovery.

Materials and methods

This study was conducted and reported according to PRISMA guidelines [26] (Additional File 1).

Search strategy

We performed a comprehensive search of MEDLINE (1985 to July 2010), PubMed, EMBASE (1985 to July 2010), the Cochrane Central Registry of Controlled Trials, Web of Science, and Scopus to identify randomised trials and cohort studies that assessed the timing of initiation of RRT in critically ill patients with AKI. We restricted our search to clinical studies performed in adult populations and published in the English language. We also excluded studies published prior to 1985 largely to reflect important advances in RRT technology and in critical care support not available in older studies.

We extended our search to include clinical trial registries (Controlled trials metaRegister) and review of abstracts from selected scientific proceedings (Society of Critical Care Medicine, European Society of Intensive Care Medicine and American Society of Nephrology). The bibliographies of all retrieved articles were also hand-searched.

Our search was based on four search themes using the Boolean operator 'OR' (Additional File 2). The first Boolean heading included keyword/MESH headings describing RRT and its different modalities. The second Boolean heading employed terms describing AKI. The third Boolean heading combined the keywords/MESH headings related to critical illness and its different populations. The fourth Boolean search included terms describing timing or initiation of therapy. The searches were combined by using the Boolean term "AND".

Study selection

Two reviewers (CK and MF/IS/SM) independently performed an initial eligibility screen of all retrieved titles and abstracts (when available). Those studies reporting original data that specifically mentioned the application of RRT in patients with AKI were selected for further review. Full-text review was independently performed by two reviewers (as above) for the following specific eligibility criteria: 1) observational cohort and/or randomised/quasi-randomised clinical trial (RCT) design; 2) adult critically ill population; 3) diagnosis of AKI; 4) description of factors related to timing of initiation of RRT; and 5) description of mortality and/or clinically relevant secondary outcomes (that is, kidney recovery and/or dialysis independence, duration of RRT, and ICU length of stay).

Disagreements between reviewers were resolved by a third reviewer or by discussion and consensus.

Data extraction

All data were extracted independently with standardised forms with subsequent discussion of any discrepancies. Data were collected on study characteristics and quality, demographics and baseline characteristics (that is, clinical/biochemical parameters at initiation of RRT), and details of RRT modality (that is, continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), continuous venovenous hemodiafiltration (CVVHDF), and intermittent hemodialysis (IHD)). The primary outcome measure was mortality. Secondary outcomes included: kidney recovery and/or dialysis independence, duration of RRT and ICU length of stay.

Assessment of methodological quality

Randomised studies were appraised using a modified version of the Jadad score [27]. Evaluation of cohort studies was done in a descriptive fashion similar to previous studies [28], incorporating the reported criteria for RRT initiation, assembly of control groups, comparability of intervention/control arms (that is, baseline characteristics, severity of illness, dialysis modality), and a description of dropouts.

Data analysis and assessment for bias

Data were analysed by STATA version 11 (StataCorp, College Station, TX. USA) and Comprehensive Meta-analysis version 2 (Biostat Inc., Englewood, NJ, USA) [29]. We assessed and quantified statistical heterogeneity for each pooled summary estimate using Cochran's Q statistic and the I2 statistic, respectively [30]. Pooled analysis was performed using the DerSimonian and Laird random effects model and reported as OR with 95% CIs. Meta-regression analysis was performed to assess for possible sources of heterogeneity according to the following pre-defined variables: criteria used to initiate RRT (that is, creatinine, urea, or other), severity of illness (Acute Physiology and Chronic Health (APACHE II) score), type of critical care unit (mixed medical/surgical vs. surgical alone), and study design (observational vs. RCT). Publication bias was assessed using Egger's regression model, and visualised with a funnel plot [31].

Results

Trial selection

A total of 1,494 citations were identified (Figure 1). After primary and secondary screen, 15 studies fulfilled all criteria for final analysis (13 articles and 2 abstracts).

Figure 1.

Figure 1

Open in a new tab

Outline of study selection process.

Trial characteristics

We found two randomised trials [10,32], four prospective cohort studies [21,33-35], and nine retrospective cohort studies [13,15,36-42]. Of these, 13 were published as articles in peer-reviewed journals and 2 studies were published as abstracts only [33,35]. Eight studies examined only patients with surgical diagnoses (that is, cardiac, abdominal, and trauma) while the remaining seven studies were from mixed medical/surgical ICUs.

Assessment of trial quality

Of the two included RCTs, one fulfilled all quality indicators [10] (Table 1), whereas the other did not describe the methods of randomisation or perform analysis by intention to treat [32]. Of the 13 cohort studies, none fulfilled all quality indicators (Table 2). Only five had a prospectively assembled control group [21,33-35,41], four had comparable modes of RRT between the early and late initiation groups [15,38,39,41], and only three studies accounted for withdrawals/loss to follow-up [34,35,38].

Table 1.

Summary of quality indicators and validity assessment of randomised trials fulfilling inclusion criteria

Randomised control trials Bouman [10] Sugahara [32]
Was the study described as randomised? Yes Yes
Was the method used to randomise described and appropriate (table of random numbers, computer generated, and so on)? Yes No
Was there a description of withdrawals and dropouts? Yes Yes
Was there intention to treat analysis? Yes No
Were control and intervention group comparable with respect to disease type and demographics? Yes No
Were the control and intervention groups comparable with respect to disease severity? Yes Yes
Was dialysis type comparable between groups in terms of dose, solution used, filtration vs dialysis, and type of membrane? Yes Yes
Open in a new tab

Table 2.

Summary of quality indicators of non-randomised studies fulfilling inclusion criteria

Observational Study Sabater [33] Bagshaw [34] Gettings [15] Elahi [38] Demirkilic [13] Liu [21] Andrade [36] Wu [42] Manche [40] Iyem [39] Shiao [41] Carl [37] Bagshaw [35]
Were criteria for initiation of RRT clearly defined in each group? Yes Yes Yes Yes Yes Yes No Yes No Yes Yes Yes Yes
Was the measurement of criterion (or lab value) for initiation of RRT reliable? Yes Yes Yes Yes Yes Yes No Yes No No Yes Yes Yes
Was control group prospectively assembled? (vs historical, or case-control) Yes Yes No No No Yes No No No No Yes No Yes
Were control and intervention group comparable with respect to disease type and demographics? No No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Were the control and intervention group comparable with respect to disease severity? No No Yes Yes Yes No Yes Yes No Yes Yes Yes Yes
Was dialysis type comparable between groups in terms of dose, solution used, filtration vs dialysis, and type of membrane? No No Yes Yes No No No No No Yes Yes No No
Was there a description of withdrawals and dropouts? No Yes No Yes No No No No No No No No Yes
Open in a new tab

Type of renal replacement therapy and criteria used for

Continuous renal replacement therapy (CRRT) was used as the principle modality for RRT in eight studies [10,13,15,32,33,38,39,41], while a combination of IHD and CRRT were used in the remaining studies [21,34-37,40,42] (Table 3). Six studies defined timing of initiation of RRT based on cut-offs in serum urea [15,21,34,35,37,42], two studies based on cut-offs in serum creatinine [33,41], one study based on the Risk, Injury, Failure, Loss, End-stage (RIFLE) criteria [3], and four based on urine output [10,32,38,40]. Three other studies used a composite of factors to designate early initiation [13,36,39]. Eight studies reported duration of RRT [10,13,15,33,34,38-40] (range 1 to 20 days). Seven studies described recovery of kidney function (RRT independence) [10,15,32,34,35,39,41].

Table 3.

Characteristics of studies included in meta-analysis

Author: Year Study design Population Modality Early (n) Late (n) Early criteria Late criteria
Bouman [10] 2002 Randomised Cardiac surgery/medical CVVH 35 36 RRT within 12 hours if Urine Output <30 ml/hr Urea >40 mmol/l or K >6.5 mmol/L
Sugahara [32] 2004 Randomised Cardiac Surgery CVVH 14 14 Urine Output <20 ml/hr Urine Output <30 cc/hr
Liu [21] 2006 Prospective Cohort Medical,Surgery CRRT/IHD 122 121 Urea <27.1 mmol/L Urea >27.1 mmol/L
Sabater [33] 2008 Prospective Cohort Medical (Septic Shock) CVVHF 9 23 Rifle Criteria (Risk, Injury)* Rifle Criteria (Failure)**
Bagshaw [34] 2009 Prospective Cohort Medical, Surgical CRRT/IHD 618 619 Urea <24.2 mmol/L Urea >24.2 mmol/L
Bagshaw [35] 2010 Prospective Cohort Medical, Surgical CRRT/IHD 117 117 Urea <23 mmol/L Urea >23 mmol/L
Gettings [15] 1999 Retrospective Cohort Trauma CAVHD and CVVHD 41 59 Urea <21.4 mmol/L Urea >21.4 mmol/L
Elahi [38] 2004 Retrospective Cohort Cardiac surgery CVVH 28 36 Urine Output <100 cc in 8 hrs K >6 mmol/L, Cr >250 mmol/L
Dermirkilic [13] 2004 Retrospective Cohort Cardiac Surgery CVVHDF 27 34 Cr >400 μmol/L, Potassium >5.5 mmol/L Oliguria
Andrade [36] 2007 Retrospective Cohort Medical (ARDS/Sepsis) IHD/SLED 18 15 On admission At 24 hours
Wu [42] 2007 Retrospective Cohort Surgical ALF IHD/CVVH 54 26 Urea < 28.6 mmol/L Urea >28.6 mmol/L
Manche [40] 2008 Retrospective Cohort Cardiac Surgery IHD 56 15 Hyperkalemia U/O <0.5 ml/kg/hour
Iyem [39] 2009 Retrospective Cohort Cardia Surgery CVVH 95 90 RRT on admission After 48 hours when anuric
Shiao [41] 2009 Retrospective Cohort Surgery/Trauma CVVH 51 47 Rifle Criteria (Risk)* Rifle Injury, Failure**
Carl [37] 2010 Retrospective Cohort Medical (sepsis) CRRT/IHD 85 62 Urea <35.7 mmol/l Urea >35.7 mmol/L
Open in a new tab

Abbreviations: Cr = creatinine (μmol/L); K = potassium (mmol/L).

RIFLE Criteria Risk: Increase in serum Creatinine by 1.5 times or urine output <0.5 ml/kg/hour × 6 hours.

RIFLE Criteria Injury: Increase in serum Creatinine by 2 times or urine output <0.5 ml/kg/hour × 12.

RIFLE Criteria Failure: Increase in serum Creatinine by 3 times or urine output <0.3 ml/kg/hour × 24.

Mortality

The OR for 28-day mortality is shown in Figure 2. Overall 28-day mortality across the 15 trials was 53.3% (1,431/2,684). Early RRT initiation was associated with reduced mortality compared to late initiation (pooled OR 0.45; 95% CI, 0.28 to 0.72, P < 0.001). However, there was significant statistical heterogeneity (I2 = 78%, Q 63.7).

Figure 2.

Figure 2

Open in a new tab

Forest plot of all 15 studies (Random Effects Model, OR, 95% CI).

Subgroup analysis was performed according to type of ICU (mixed vs. surgery only; Figure 3). The overall effect estimate of the surgical group (OR 0.31, 95% CI 0.16 to 0.58, n = 8) was not statistically different than that of the mixed group (OR 0.71, 95% CI 0.40 to 1.24, n = 7) with a P-value of 0.06. There was also no statistical difference in the overall effect estimates between prospective and retrospective studies. There was also no statistically significant effect on the pooled OR for mortality when analysed according to baseline APACHE II scores, creatinine, and urea levels. Therefore, meta-regression analyses with these variables could not account for the large amounts of heterogeneity observed.

Figure 3.

Figure 3

Open in a new tab

Forest plot stratified for surgery only (n = 8) vs. Medical (mixed, n = 7).

Secondary outcomes

Five studies [15,32,34,39,41] (of seven reporting data) described a higher rate of kidney recovery to dialysis independence at hospital discharge for patients receiving early RRT (Table 4). Pooled analysis of these seven studies showed a non-significant summary estimate favouring early RRT (OR 0.62, 95% CI 0.34 to 1.13, I2 = 69.6%; Figure 4).

Table 4.

Baseline characteristics and outcomes in intervention and control groups in 14 studies included in meta-analysis

Author: Year Creatinine* Urea* APACHE II score Dialysis-Free (%) Duration of RRT (days) ICU Length of Stay (days) Mortality at 28-days (%)
Early Late Early Late Early Late Early Late Early Late Early Late Early Late
Bouman [10] 2002 5 (4)** 6 (4)** NR NR 21.7(5.5) 23.6(8.3) 17 22 5.7 6.6 NR NR 11/35 9/36
Sugahara [32] 2004 256 265 NR NR 19(2) 18(3) 10 2 NR NR NR NR 2/14 12/14
Liu [21] 2006 301 415 16.9 41.0 NR NR NR NR NR NR NR NR 43/122 50/121
Sabater [33] 2008 NR NR NR NR 24(8) 29(9) NR NR 6 7 NR NR 1/9 16/23
Bagshaw [34] 2009 230 396 15.0 (5.4) 38.8 (12) 11.1 (3)§ 10.7 (3)§ 91 74 4 (2-13) 6 (2-15) 13 (7-24) 13 (6-28) 392/618 380/619
Bagshaw [35] 2010 273 489 13.5 38.0 31(9.3) 28.1(6.7) 22 30 NR NR 12 14 67/117 54/117
Gettings [15] 1999 148 238 15.2 (4.6) 33.7 (10) NR NR 16 11 17.7 20.2 NR NR 25/41 47/59
Elahi [38] 2004 328 379 23.9 (12) 26.8 (22) NR NR NR NR 4.61 4.57 8.5 12.5 8/28 12/36
Dermirkilic [13] 2004 NR NR NR NR NR NR NR NR 4.32 4.56 7.8 12.4 8/27 15/34
Andrade [36] 2007 583 548 73.9 (6.6) 82.8 (6.9) 24.5 (1.4) 26 (1.2) NR NR NR NR 20 13.6 3/18 10/15
Wu [42] 2007 256 415 16.5 (7) 42.4 (12) 18.2 (5.1) 20.5 (5.3) NR NR NR NR NR NR 34/54 22/26
Manche [40] 2008 233 404 14.4 (3.1) 35.2 (18) NR . NR NR 1.8 6.5 NR NR 14/56 13/15
Iyem [39] 2009 186 256 19.5 (2.7) 24.3 (1.9) NR . 95 87 1.6 4.1 2 4 5/95 6/90
Shiao [41] 2009 292 336 24.6 (14) 29.2 (14) 18.2 (5.4) 18.8 (6.3) 21 10 NR NR NR NR 22/51 35/47
Carl [37] 2010 442 514 23.6 (7.2) 48.9 (10) 24.8 (6.2) 24.7 (6.1) NR NR NR NR 27 39.1 44/85 42/62
Open in a new tab

* Continuous variables reported as means and standard deviations when given.

** Bouman et al. reported creatinine clearance (ml/minute).

Figure 4.

Figure 4

Open in a new tab

Forest plot of seven studies reported RRT independence (OR, 95% CI).

Due to the variability in the reporting of the remaining secondary outcomes of interest and evidence of significant statistical heterogeneity, we did not perform a pooled analysis for RRT duration or ICU length of stay. Rather, we present the data on these secondary outcomes descriptively (Table 4). Seven studies [10,13,15,33,34,39,40] (of eight reported data) described shorter duration of RRT in those receiving early RRT. Five studies [13,35,37-39] (of six reported data) described a reduction in ICU length of stay in those receiving early RRT.

Publication bias

We assessed for publication bias using Egger's linear regression test and found statistical evidence of bias (beta-coefficient of the bias estimate = -3.19, 95% CI = -4.58 to -1.81, P = 0.0003). There appears to be publication bias towards smaller studies reporting positive results (that is, mortality benefit associated with early initiation of RRT) (Figure 5).

Figure 5.

Figure 5

Open in a new tab

Funnel plot of all 15 studies. X-axis is log of risk ratio of death. Y-axis is Standard error of Log Risk ratio of death. Egger's regression (plot not shown): Bias (intercept) -3.19736, P-value = 0.00025 (null hypothesis stating no small study effects is REJECTED).

Discussion

This systematic review and meta-analysis of 15 unique studies compared "early" versus "late" initiation of RRT in critically ill patients with AKI and suggests that earlier initiation is associated with improved survival. There is insufficient evidence to conclude that kidney recovery to dialysis independence is influenced by the timing of RRT initiation.

To our knowledge, this is the first systematic review to address the question of whether timing of RRT initiation has an important impact on survival and kidney recovery in the critically ill. Previous work on this issue was not specifically focused on critically ill patients supported in an ICU environment [43]. Moreover, in contrast to previous work [43], we intentionally excluded older studies (that is, published before 1985) due to the considerable advances in available technology for providing RRT, the marked demographic transition critically ill populations (that is, older, more comorbid illness, receiving more complex procedures/interventions), and the evolution in general of interventions and technology available to support the critically ill. Accordingly, our systematic review is uniquely focused on how the timing of initiation of RRT impacts survival and kidney recovery in modern ICU practice. Despite these strengths, inferences from our study are limited for two important reasons. First, we found significant statistical heterogeneity. As such, we were unable to calculate effect sizes for all secondary outcomes of interest. We attribute the observed heterogeneity to marked variability between published studies in study design and quality, which we were unable to account for in sensitivity analyses. Second, we found evidence of publication bias towards smaller studies where early initiation of RRT was associated with a survival benefit. As a consequence, the magnitude of the pooled effect estimate may overstate the `true` benefit, if any, of early compared with late RRT initiation.

Our findings are broadly consistent with those reported previously [43]. However, our study more specifically focused on the critically ill and benefited from the recent publication of several additional studies. In a previous meta-analysis [43], Seabra and colleagues explored heterogeneity but found no association between effect estimate and date of publication, RRT modality, sample size, duration of study follow-up, and study quality. Likewise, we could not account for the observed heterogeneity by meta-regression according to patient and population characteristics including type of ICU, severity of illness (baseline APACHE II scores), and metabolic derangements (baseline creatinine and urea levels). Accordingly, the heterogeneity observed is most likely explained by differences in study design (that is, clinical trial vs. cohort study), operational definitions for RRT timing (that is, clinical vs. biochemical criteria) and the inability to account for heterogeneity in clinical practice patterns. Our study has several notable strengths compared to earlier work. First, we have included eight additional clinical studies [32-35,37,39-41]. Second, we excluded studies for which there was no comparable control group [44-46], as well as older studies that have no applicability to current ICU practice [11,16,22]. Third, we have found evidence of publication bias and explain how older reports from smaller studies favouring early RRT may have influenced our summary estimates.

The utilization of RRT in critically ill patients with AKI is relatively common [7,47]. Importantly, the incidence is increasing [48]. These critically ill patients have a risk of death approaching 60% [2,7]. The decision to initiate RRT is a modifiable intervention for these patients; however, it also represents a significant escalation in the complexity and cost of their support. The current uncertainty over the optimal time to initiate RRT is a critical knowledge gap in evidence that has almost certainly contributed to the wide variation in clinical practice. Moreover, this has been further compounded by a lack of consensus and a standardised definition for "early" RRT [24]. There are currently numerous clinical, biochemical, and physiological factors that are considered when deciding to initiate RRT; however, there remains no consensus guidelines or rigorous evidence to guide clinicians on this important issue [24]. This is analogous to the uncertainty regarding the optimal dose-intensity of RRT in critically ill patients with AKI that was largely settled by the recent publication of two large randomised trials [49,50]. A future randomised trial will ideally require broad-based consensus on eligibility criteria and operational definitions for 'early' and 'standard' initiation of RRT in critically ill patients to ensure feasibility and adequate separation of treatment arms. In addition, such a study may benefit from the integration of novel kidney-injury specific biomarkers to aid in the prediction of those who will develop worsening AKI. Understanding methods to further optimise the delivery of acute RRT for critically ill patients with AKI is of utmost importance to improve patient outcomes, guide resource utilization, and rationally deliver standardised care.

Conclusions

In summary, our systematic review suggests that early institution of RRT in critically ill patients with AKI may have a measurable benefit on survival. However, existing evidence is based on mostly smaller studies with important differences in design and quality, and only two randomised trials. In the absence of novel evidence from a multi-centric suitably-designed randomised trial, conclusive treatment recommendations on the optimal time to initiate RRT remain uncertain. Future investigation must be targeted at defining acceptable "early" RRT criteria and determining whether "early" initiation of RRT, compared with the current standard-of-care, has an important modifying influence on short- and long-term survival and kidney recovery.

Key messages

• The overall design and quality of studies comparing early versus late initiation of RRT in critically ill patients with AKI is low.

• Earlier initiation of RRT in critically ill patients with AKI may have a beneficial impact on survival.

• A well-designed randomised trial targeting acceptable 'early' compared with "standard" criteria for RRT initiation in homogenous patient populations is needed to definitively determine the effect of RRT timing on patient outcomes.

Abbreviations

AKI: acute kidney injury; AKIN: Acute Kidney Injury Network; APACHE II: Acute Physiology And Chronic Health Evaluation II; CI: confidence interval; CRRT: continuous renal replacement therapy; CVVH: continuous venovenous hemofiltration; CVVHD: continuous venovenous hemodialysis; CVVHDF: continuous venovenous hemodiafiltration; IHD: intermittent hemodialysis; OR: odds ratio; RCT: randomised control trial; RRT: renal replacement therapy.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CJK carried out primary study search, extracted data, performed statistical analysis and drafted the manuscript. MF carried out the primary study search, extracted data, performed statistical analysis and tabulated quality indicators of the studies. IS and SM carried out the primary study search and extracted data. AL carried out statistical analysis and helped draft the manuscript. RW helped draft/revise the manuscript. SMB conceived the idea, participated in its design and coordination and drafted/revised the manuscript. All authors read and approved the final manuscript.

Authors' information

Sean Bagshaw is supported by a Clinical Investigator Award from the Alberta Innovates - Health Solutions (formerly Alberta Heritage Foundation for Medical Research). Alexander Leung is supported by the Alberta Innovates - Health Solutions Clinical Fellowship, the Canadian Institutes for Health Research Fellowship, and the John A. Buchanan Research Chair at the University of Calgary.

Supplementary Material

Additional File 1

The PRISMA checklist. Summary of the completed checklist of quality measures for reporting of systematic reviews and meta-analyses.

Click here for file (59KB, DOC)
Additional File 2

Summary of search strategy. Detailed summary of search terms and strategy used for systematic literature search.

Click here for file (23.5KB, DOC)

Contributor Information

Constantine J Karvellas, Email: dean.karvellas@ualberta.ca.

Maha R Farhat, Email: mrfarhat@partners.org.

Imran Sajjad, Email: isajjad@partners.org.

Simon S Mogensen, Email: simonskibsted@gmail.com.

Alexander A Leung, Email: aacleung@ucalgary.ca.

Ron Wald, Email: waldr@smh.ca.

Sean M Bagshaw, Email: bagshaw@ualberta.ca.

Acknowledgements

Special thanks to Michael Stoto and Shenaz Alidina for advice on study design.

This work was performed at the University of Alberta and the Harvard School of Public Health.

References

  1. Ahlstrom A, Tallgren M, Peltonen S, Rasanen P, Pettila V. Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med. 2005;31:1222–1228. doi: 10.1007/s00134-005-2681-6. [DOI] [PubMed] [Google Scholar]
  2. Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M, Godinez-Luna T, Svenson LW, Rosenal T. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care. 2005;9:R700–709. doi: 10.1186/cc3879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10:R73. doi: 10.1186/cc4915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Korkeila M, Ruokonen E, Takala J. Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med. 2000;26:1824–1831. doi: 10.1007/s001340000726. [DOI] [PubMed] [Google Scholar]
  5. Manns B, Doig CJ, Lee H, Dean S, Tonelli M, Johnson D, Donaldson C. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med. 2003;31:449–455. doi: 10.1097/01.CCM.0000045182.90302.B3. [DOI] [PubMed] [Google Scholar]
  6. Morgera S, Kraft AK, Siebert G, Luft FC, Neumayer HH. Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis. 2002;40:275–279. doi: 10.1053/ajkd.2002.34505. [DOI] [PubMed] [Google Scholar]
  7. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813–818. doi: 10.1001/jama.294.7.813. [DOI] [PubMed] [Google Scholar]
  8. Clark WR, Letteri JJ, Uchino S, Bellomo R, Ronco C. Recent clinical advances in the management of critically ill patients with acute renal failure. Blood Purif. 2006;24:487–498. doi: 10.1159/000095929. [DOI] [PubMed] [Google Scholar]
  9. Matson J, Zydney A, Honore PM. Blood filtration: new opportunities and the implications of systems biology. Crit Care Resusc. 2004;6:209–217. [PubMed] [Google Scholar]
  10. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30:2205–2211. doi: 10.1097/00003246-200210000-00005. [DOI] [PubMed] [Google Scholar]
  11. Conger JD. A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma. 1975;15:1056–1063. doi: 10.1097/00005373-197512000-00003. [DOI] [PubMed] [Google Scholar]
  12. Cosentino F, Chaff C, Piedmonte M. Risk factors influencing survival in ICU acute renal failure. Nephrol Dial Transplant. 1994;9 Suppl 4:179–182. [PubMed] [Google Scholar]
  13. Demirkilic U, Kuralay E, Yenicesu M, Caglar K, Oz BS, Cingoz F, Gunay C, Yildirim V, Ceylan S, Arslan M, Vural A, Tatar H. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg. 2004;19:17–20. doi: 10.1111/j.0886-0440.2004.04004.x. [DOI] [PubMed] [Google Scholar]
  14. Elahi M, Asopa S, Pflueger A, Hakim N, Matata B. Acute kidney injury following cardiac surgery: impact of early versus late haemofiltration on morbidity and mortality. Eur J Cardiothorac Surg. 2009;35:854–863. doi: 10.1016/j.ejcts.2008.12.019. [DOI] [PubMed] [Google Scholar]
  15. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med. 1999;25:805–813. doi: 10.1007/s001340050956. [DOI] [PubMed] [Google Scholar]
  16. Kennedy AC, Luke RG, Linton AL, Eaton JC, Gray MJ. Results of haemodialysis in severe acute tubular necrosis. A report of fifty-seven cases. Scott Med J. 1963;8:97–108. doi: 10.1177/003693306300800302. [DOI] [PubMed] [Google Scholar]
  17. Kleinknecht D, Jungers P, Chanard J, Barbanel C, Ganeval D. Uremic and non-uremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis. Kidney Int. 1972;1:190–196. doi: 10.1038/ki.1972.26. [DOI] [PubMed] [Google Scholar]
  18. Kornhall S. Acute renal failure in surgical disease with special regard to neglected complications. A retrospective study of 298 cases treated during the period 1960-1968. Acta Chir Scand Suppl. 1971;419:3–64. [PubMed] [Google Scholar]
  19. Kresse S, Schlee H, Deuber HJ, Koall W, Osten B. Influence of renal replacement therapy on outcome of patients with acute renal failure. Kidney Int Suppl. 1999. pp. S75–78. [DOI] [PubMed]
  20. Lange HW, Aeppli DM, Brown DC. Survival of patients with acute renal failure requiring dialysis after open heart surgery: early prognostic indicators. Am Heart J. 1987;113:1138–1143. doi: 10.1016/0002-8703(87)90925-2. [DOI] [PubMed] [Google Scholar]
  21. Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1:915–919. doi: 10.2215/CJN.01430406. [DOI] [PubMed] [Google Scholar]
  22. Parsons FM, Hobson SM, Blagg CR, McCracken BH. Optimum time for dialysis in acute reversible renal failure. Description and value of an improved dialyser with large surface area. Lancet. 1961;1:129–134. doi: 10.1016/S0140-6736(61)91309-5. [DOI] [PubMed] [Google Scholar]
  23. Splendiani G, Mazzarella V, Cipriani S, Pollicita S, Rodio F, Casciani CU. Dialytic treatment of rhabdomyolysis-induced acute renal failure: our experience. Ren Fail. 2001;23:183–191. doi: 10.1081/JDI-100103490. [DOI] [PubMed] [Google Scholar]
  24. Gibney RT, Bagshaw SM, Kutsogiannis DJ, Johnston C. When should renal replacement therapy for acute kidney injury be initiated and discontinued? Blood Purif. 2008;26:473–484. doi: 10.1159/000157325. [DOI] [PubMed] [Google Scholar]
  25. Kellum JA, Mehta RL, Levin A, Molitoris BA, Warnock DG, Shah SV, Joannidis M, Ronco C. Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process. Clin J Am Soc Nephrol. 2008;3:887–894. doi: 10.2215/CJN.04891107. [DOI] [PubMed] [Google Scholar]
  26. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100. doi: 10.1371/journal.pmed.1000100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12. doi: 10.1016/0197-2456(95)00134-4. [DOI] [PubMed] [Google Scholar]
  28. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, Linde-Zwirble WT. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med. 2002;28:29–37. doi: 10.1007/s00134-001-1159-4. [DOI] [PubMed] [Google Scholar]
  29. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. doi: 10.1136/bmj.c3691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558. doi: 10.1002/sim.1186. [DOI] [PubMed] [Google Scholar]
  31. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sugahara S, Suzuki H. Early start on continuous hemodialysis therapy improves survival rate in patients with acute renal failure following coronary bypass surgery. Hemodial Int. 2004;8:320–325. doi: 10.1111/j.1492-7535.2004.80404.x. [DOI] [PubMed] [Google Scholar]
  33. Sabater J, Perez XL, Albertos R, Gutierrez D, Labad X. Acute renal failure in septic shock. Should we consider different continuous renal replacement therapies on each RIFLE score stage? Intensive Care Med. 2009;35:S239. [Google Scholar]
  34. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care. 2009;24:129–140. doi: 10.1016/j.jcrc.2007.12.017. [DOI] [PubMed] [Google Scholar]
  35. Bagshaw SM, Wald R, Barton J, Burns K, Friedrich JO, House AA, James MT, Levin A, Moist L, Pannu N, Stollery DE, Walsh MW. Initiation of renal replacement therapy in critically ill patients with acute kidney injury - a prospective multi-centre observational study [abstract] Submitted to the 2010 AKI Critical Care Nephrology Conference, Edmonton, Canada; 2010. [DOI] [PubMed] [Google Scholar]
  36. Andrade L, Cleto S, Seguro A. Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality. Clin J Am Soc Nephrol. 2007;2:739–744. doi: 10.2215/CJN.00680207. [DOI] [PubMed] [Google Scholar]
  37. Carl DE, Grossman C, Behnke M, Sessler CN, Gehr TW. Effect of timing of dialysis on mortality in critically ill, septic patients with acute renal failure. Hemodial Int. 2010;14:11–17. doi: 10.1111/j.1542-4758.2009.00407.x. [DOI] [PubMed] [Google Scholar]
  38. Elahi MM, Lim MY, Joseph RN, Dhannapuneni RR, Spyt TJ. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg. 2004;26:1027–1031. doi: 10.1016/j.ejcts.2004.07.039. [DOI] [PubMed] [Google Scholar]
  39. Iyem H, Tavli M, Akcicek F, Buket S. Importance of early dialysis for acute renal failure after an open-heart surgery. Hemodial Int. 2009;13:55–61. doi: 10.1111/j.1542-4758.2009.00347.x. [DOI] [PubMed] [Google Scholar]
  40. Manche A, Casha A, Rychter J, Farrugia E, Debono M. Early dialysis in acute kidney injury after cardiac surgery. Interact Cardiovasc Thorac Surg. 2008;7:829–832. doi: 10.1510/icvts.2008.181909. [DOI] [PubMed] [Google Scholar]
  41. Shiao CC, Wu VC, Li WY, Lin YF, Hu FC, Young GH, Kuo CC, Kao TW, Huang DM, Chen YM, Tsai PR, Lin SL, Chou NK, Lin TH, Yeh YC, Wang CH, Chou A, Ko WJ, Wu KD. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery. Crit Care. 2009;13:R171. doi: 10.1186/cc8147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wu VC, Ko WJ, Chang HW, Chen YS, Chen YW, Chen YM, Hu FC, Lin YH, Tsai PR, Wu KD. Early renal replacement therapy in patients with postoperative acute liver failure associated with acute renal failure: effect on postoperative outcomes. J Am Coll Surg. 2007;205:266–276. doi: 10.1016/j.jamcollsurg.2007.04.006. [DOI] [PubMed] [Google Scholar]
  43. Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis. 2008;52:272–284. doi: 10.1053/j.ajkd.2008.02.371. [DOI] [PubMed] [Google Scholar]
  44. Durmaz I, Yagdi T, Calkavur T, Mahmudov R, Apaydin AZ, Posacioglu H, Atay Y, Engin C. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg. 2003;75:859–864. doi: 10.1016/S0003-4975(02)04635-0. [DOI] [PubMed] [Google Scholar]
  45. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med. 2009;37:803–810. doi: 10.1097/CCM.0b013e3181962316. [DOI] [PubMed] [Google Scholar]
  46. Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S, Zamperetti N, Brendolan A, D'Intini V, Tetta C, Bellomo R, Ronco C. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med. 2006;32:80–86. doi: 10.1007/s00134-005-2815-x. [DOI] [PubMed] [Google Scholar]
  47. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA. 2009;302:1179–1185. doi: 10.1001/jama.2009.1322. [DOI] [PubMed] [Google Scholar]
  48. Bagshaw SM, George C, Bellomo R. Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care. 2007;11:R68. doi: 10.1186/cc5949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627–1638. doi: 10.1056/NEJMoa0902413. [DOI] [PubMed] [Google Scholar]
  50. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7–20. doi: 10.1056/NEJMoa0802639. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Additional File 1

The PRISMA checklist. Summary of the completed checklist of quality measures for reporting of systematic reviews and meta-analyses.

Click here for file (59KB, DOC)
Additional File 2

Summary of search strategy. Detailed summary of search terms and strategy used for systematic literature search.

Click here for file (23.5KB, DOC)

Articles from Critical Care are provided here courtesy of BMC

RESOURCES